Wen Song Tan
Directeur/Membre du Conseil chez Tasly Biopharmaceuticals Co., Ltd.
Profil
Wen Song Tan is an Independent Non-Executive Director at Tasly Biopharmaceuticals Co., Ltd.
and VP-Cell Engineering & Transgenic Organism Branch at Chinese Society For Cell Biology.
He was the Director-Higher Education at East China University of Science & Technology from 2009 to 2015 and a Member-Tissue Engineering & Regenerative Medicine at Chinese Society of Biomedical Engineering from 2013 to 2017.
Dr. Tan earned his doctorate degree from East China University of Science & Technology in 1993.
Postes actifs de Wen Song Tan
Sociétés | Poste | Début |
---|---|---|
Tasly Biopharmaceuticals Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 15/04/2019 |
Chinese Society For Cell Biology | Corporate Officer/Principal | 01/10/2016 |
Anciens postes connus de Wen Song Tan
Sociétés | Poste | Fin |
---|---|---|
Chinese Society of Biomedical Engineering | Corporate Officer/Principal | 01/04/2017 |
East China University of Science & Technology | Corporate Officer/Principal | 01/12/2015 |
Formation de Wen Song Tan
East China University of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Chinese Society of Biomedical Engineering | |
Tasly Biopharmaceuticals Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Health Technology |
Chinese Society For Cell Biology |